APPLICATION
ANDA077868
TYPE
ANDA
ORIGINAL APPROVAL
2009-04-15
LATEST ACTION
2014-10-25
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
TOPIRAMATEDiscontinued
TOPIRAMATE 25MG · CAPSULE · ORAL
TOPIRAMATEDiscontinued
TOPIRAMATE 15MG · CAPSULE · ORAL
Approval history
2014-10-25Labeling · Supplement 8AP
2014-10-25Labeling · Supplement 11 · standardAP
2011-08-18Labeling · Supplement 7AP
2010-12-23Labeling · Supplement 3AP
2010-01-28Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.